Reach Us +44-1522-440391
Administration Of Tea Phenols In Bulk And Nanoparticle Form Reduces And Increases Respectively DNA Damage In Human Lymphocytes From Colon Cancer Patients And Healthy Individuals Treated In Vitro With Platinum Based Chemotherapeutic Drugs | 32124
ISSN: 2161-1165

Epidemiology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Administration of tea phenols in bulk and nanoparticle form reduces and increases respectively DNA damage in human lymphocytes from colon cancer patients and healthy individuals treated in vitro with platinum based chemotherapeutic drugs

3rd International Conference on Epidemiology & Public Health

Diana Anderson

Keynote: Epidemiology (Sunnyvale)

DOI: 10.4172/2161-1165.S1.010


Tea catechin epigallocatechin-3-gallate (EGCG), and other polyphenols such as theaflavins are increasingly proving useful as
chemopreventives in a number of human cancers, and can also affect normal cells. The polyphenols in tea are known to have
antioxidant properties that can quench free radical species, and also pro-oxidant activities that appear to be responsible for the
induction of apoptosis in tumour cells. The bioavailability of these natural compounds is an important factor that determines their
efficacy. Nanoparticle-mediated delivery techniques of EGCG and theaflavins have been found to improve their bioavailability
to a level that could benefit their effectiveness as chemopreventives. The present study was conducted to compare the effects of
theaflavins and EGCG, when used in the bulk form and in the biopolymer (polylactide-co-glycolide)-based nanoparticle form,
in oxaliplatin- and satraplatin-treated lymphocytes as surrogate cells from colorectal cancer patients and healthy volunteers. The
results of DNA damage measurements by the Comet assay revealed opposite trends in bulk and nanoparticle forms of theaflavins
as well as EGCG. Both the compounds in the bulk form produced statistically significant concentration-dependent reductions in
DNA damage in oxaliplatin- or satraplatin-treated lymphocytes. In contrast when used in the nanoparticle form both theaflavins
and EGCG, although initially causing a reduction, produced a concentration-dependent statistically significant increase in DNA
damage in the lymphocytes. These observations support the notion that theaflavins and EGCG act as both antioxidants and prooxidants,
depending on the form in which they are administered under the conditions of investigation.


Diana Anderson completed her PhD at the University of Manchester, UK in the Faculty of Medicine. She is the Established Chair in Biomedical Sciences at the University of
Bradford. She has published more than 450 papers, 8 books, successfully supervised 30 PhD students, has an Hirsch factor of 51. She is Editor –in- Chief of a Book Series
for the Royal Society of Chemistry and is Consultant to many International Organisations, such as the World Health Organisation/ International Programme of Chemical

Relevant Topics